Conversely, ANGPTL-4 displayed an increasing tendency from the early (acute infection/mild fibrosis) to late (cirrhosis/HCC) stages, but in a non-linear way since it peaked in patients with advanced fibrosis. Here, ANGPTL4 is linked to hepatocellular carcinoma.